Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.
ACS Med Chem Lett
; 7(1): 40-5, 2016 Jan 14.
Article
in En
| MEDLINE
| ID: mdl-26819663
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Med Chem Lett
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
United States